Corstasis to present pivotal trial data on Bumetanide Nasal Spray at AHA 2024, highlighting safety, and efficacy. #AHA2024. Home is where the heart is ...
Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may ...
'Non-oral migraine medications, such as injectables and nasal sprays, do not rely on the digestive system to be absorbed and can offer the potential for faster relief from migraine symptoms in as ...
Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...
Some signs indicate efforts like the ones in Boston could be helping.
A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...
Dr Oscar Duke has spoken on BBC Morning Live about the recent concerns surrounding a popular cold and flu component, as the ...
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
The FDA proposed a ban on phenylephrine, a common decongestant found in cold and cough medications. Here’s why and a list of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback